13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001104659-24-116967
Total Value
$1.08B
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dyne Therapeutics, Inc. | DYN | 8,020,136 | $288.1M | 26.71% |
| 2 | Kymera Therapeutics, Inc. | KYMR | 4,896,462 | $231.7M | 21.48% |
| 3 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $147.8M | 13.70% |
| 4 | Disc Medicine, Inc. | IRON | 2,509,456 | $123.3M | 11.43% |
| 5 | Q32 Bio, Inc. | QTTB | 2,092,106 | $93.3M | 8.65% |
| 6 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $89.6M | 8.30% |
| 7 | Korro Bio, Inc. | KRRO | 1,137,149 | $38.0M | 3.52% |
| 8 | Generation Bio, Co. | 37148K100 | 8,279,484 | $20.5M | 1.90% |
| 9 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $19.8M | 1.84% |
| 10 | Tectonic Therapeutics, Inc. | TECX | 378,447 | $11.5M | 1.06% |
| 11 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $8.7M | 0.80% |
| 12 | Aerovate Therapeutics, Inc. | 008064107 | 1,799,232 | $3.8M | 0.35% |
| 13 | Dianthus Therapeutics, Inc. | DNTH | 76,979 | $2.1M | 0.20% |
| 14 | Spero Therapeutics, Inc. | SPRO | 402,885 | $539,866 | 0.05% |